Patients with rheumatoid arthritis increased their leg muscle volume when treated with an anti-rheumatic drug, offering new hope for improved muscle health. Publishing in the prestigious journal, The ...
RENO, Nev.--(BUSINESS WIRE)--Strykagen Corp., the exclusive research partner of Sarcomatrix Therapeutics, Corp., a clinical-stage biotechnology company focused on the discovery and development of ...
Researchers at the University of Houston are pushing the boundaries of biomedical innovation with a discovery that could ...
Skeletal muscle atrophy, or wasting, is a devastating and often irreversible syndrome during the aging process and for patients with advanced cancer. Muscle wasting involves a decrease in muscle mass ...
HOUSTON – A newly identified gene, atrogin-1, is involved in muscle loss associated with cancer, diabetes, fasting and kidney disease as well as in the atrophy occurring with disuse, inactivity, and ...